EPISODE · Dec 30, 2018 · 10 MIN
Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach
from Outbreak News
The biotech company, Valneva announced this month about the promising work and progress on two vaccine candidates--the mosquito borne virus, chikungunya and Lyme disease. On today's show I am joined by Valneva President and CEO, Thomas Lingelbach to discuss the latest on these vaccine candidates.
Embed this episode
NOW PLAYING
Chikungunya and Lyme vaccine candidates with Valneva CEO Thomas Lingelbach
0:00
10:56
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Outbreak News?
This episode is 10 minutes long.
When was this Outbreak News episode published?
This episode was published on December 30, 2018.
Can I download this Outbreak News episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!